Bringing together science, technology, and clinical intelligence, Elekta is working towards a future where everyone can benefit from accurate and individualized radiation therapy treatments.
Elekta is the leading company in precision radiation medicine. With nearly 4,000 employees worldwide, their commitment is to ensure all people with cancer worldwide have access to and benefit from more accurate and personalized radiation therapy treatments. Together with INVAP as its commercial partner in Argentina, they have stimulated the market at the national and Latin American level for the past 15 years.
Founded in 1985 and based in Belgium, IBA focuses its activities on proton therapy, radiopharmacy, particle accelerators, and dosimetry.
With more than 1,400 employees, IBA considers itself a world leader in the design, production and marketing of innovative solutions for the diagnosis and treatment of cancer and other serious diseases. Since 2015, it has been a commercial partner of INVAP in Argentina, providing joint solutions for national and Latin American clients.
Based on innovative technologies, Orfit develops and produces the most accurate and reliable thermoplastic materials for medical devices improving the treatment of radiation therapy patients.
ORFIT's thermoplastic masks effectively immobilize the patient to a point where movement is limited to less than 1.5 millimeters. Combining these thermoplastic masks with other systems results in optimal precision, comfort and reproducibility by immobilizing and positioning patients for radiation therapy treatments.